Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03194191
Other study ID # P150951
Secondary ID
Status Not yet recruiting
Phase N/A
First received May 23, 2017
Last updated June 27, 2017
Start date September 2017
Est. completion date May 2019

Study information

Verified date April 2017
Source Assistance Publique - Hôpitaux de Paris
Contact Stéphanie Nicolian, Midewife
Phone 0033 6 25 71 08 64
Email snicolian@yahoo.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.

GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.


Description:

Scientific justification:

- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.

Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.

- To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.

- Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.

Population:

The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.

Objectives:

- Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.

- Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .

Study design:

- Study Type: Multicentre, Interventional, randomized, 2 parallel groups

- Endpoint Classification: Efficacy Study

- Intervention Model: Parallel Assignment

- Masking: Single blind (patient blinded to intervention)

- Primary Purpose: Treatment

- One acupuncture session weekly for 4 consecutive weeks

Visits:

- Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.

- Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.

- Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.

- End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date May 2019
Est. primary completion date January 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age > 18 years

- Singleton pregnancy

- Gestational age = 16 weeks + 0 day and = 32 weeks + 6 days

- Insomnia Severity Index = 10

- Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion

- Patient understanding the study

- Informed consent signed

- Social insurance available at inclusion and until the end of pregnancy

Exclusion Criteria:

- Threatened premature labor

- Small fetus for gestational age

- Pre-eclampsia

- Insomnia starting before pregnancy

- Use of psychotropic drugs before pregnancy

- Use of recreational drugs during pregnancy

- Known psychiatric disorder

- Anticoagulant therapy

- Patient reporting insomnia results from chronic or acute pain

- Obstructive sleep apnea (OSA) requiring treatment

- Patient under antidepressant therapy

- Patient under legal guardianship or deprived of freedom

Study Design


Related Conditions & MeSH terms

  • Insomnia
  • Sleep Initiation and Maintenance Disorders

Intervention

Device:
Acupuncture needles
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Outcome

Type Measure Description Time frame Safety issue
Primary Insomnia severity index (ISI) Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session Inclusion visit and 5 weeks after the first acupuncture session
Secondary Pittsburgh Sleep Quality Index (PSQI) Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session Inclusion visit and 5 weeks after the first acupuncture session
Secondary Hospital Anxiety and Depression Scale (HADS) Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session Inclusion visit and 5 weeks after the first acupuncture session
Secondary Cumulated dose of each psychotropic medicine During the study period, the patients will note on a logbook the daily use of any drug. Inclusion visit and 5 weeks after the first acupuncture session
Secondary Cumulated dose of alcohol During the study period, the patients will note on a logbook the daily use of alcohol. Inclusion visit and 5 weeks after the first acupuncture session
Secondary Cumulated dose of tobacco During the study period, the patients will note on a logbook the daily use of tobacco. Inclusion visit and 5 weeks after the first acupuncture session
Secondary Cumulated dose of cannabis During the study period, the patients will note on a logbook the daily use of cannabis. Inclusion visit and 5 weeks after the first acupuncture session
Secondary Cumulated dose of other recreational substances or medicine During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine. Inclusion visit and 5 weeks after the first acupuncture session
Secondary Difference in the frequency of restless leg syndrome According to the guidelines of the International Restless Legs Syndrome Study Group.
The diagnosis of restless leg will rely on the presence of all of the following criteria:
Desire to move the extremities usually associated with discomfort or disagreeable sensations in the extremities.
Motor Restlessness-patients move to relieve the discomfort, for example walking, or to provide a counter-stimulus to relieve the discomfort, for example, rubbing the legs.
Symptoms are worse at rest with at least temporary relief by activity.
Symptoms are worse later in the day or at night.
Inclusion visit and 5 weeks after the first acupuncture session
Secondary Perinatal outcome - Gestational age at birth The gestational age at birth of the newborn will be recorded. At birth
Secondary Perinatal outcome - birth weight The weight (in gr) at birth of the newborn will be recorded. At birth
Secondary Perinatal outcome - birth height The height (in cm) at birth of the newborn will be recorded. At birth
Secondary Perinatal outcome - sex The sex of the newborn will be recorded. At birth
Secondary Perinatal outcome - perinatal mortality The perinatal mortality will be recorded. At birth
Secondary Perinatal outcome - five minutes Apgar score The five minutes Apgar score will be recorded. At birth
Secondary Perinatal outcome - cesarean section rate Cesarean section rate will be recorded. At birth.
See also
  Status Clinical Trial Phase
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT05963542 - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia N/A
Completed NCT06339853 - Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia N/A
Recruiting NCT04069247 - Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia N/A
Completed NCT04493593 - Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility N/A
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Recruiting NCT06278077 - Neurexan - a Clinical Trial in Short-Term Insomnia Patients Phase 2
Completed NCT04661306 - The Better Sleep for Supporters With Insomnia Study N/A
Recruiting NCT06207279 - Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
Recruiting NCT06006299 - Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC) N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Completed NCT04564807 - Testing an Online Insomnia Intervention N/A
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT04035200 - Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation Phase 2
Active, not recruiting NCT05027438 - Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention N/A
Recruiting NCT06053840 - An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia Phase 4
Not yet recruiting NCT06348082 - Project Women's Insomnia Sleep Health Equity Study (WISHES) N/A
Not yet recruiting NCT06363799 - Osteopathic Protocol for Insomnia in College Students N/A
Not yet recruiting NCT06025968 - Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis N/A
Not yet recruiting NCT05991492 - Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application N/A